For instance, some researchers claimed that CCR5 could promote breast cad gastric cancer progression, while others demonstrated that the expression of CCR5 in both CD4+ and CD8+ T cells was critical in boosting anti-tumor immune response [8–11]. The gene discussed is CD8A; the disease is neoplasm.